-
Mashup Score: 2Cardiopulmonary Exercise Testing With Simultaneous Echocardiography: Blueprints of a Dyspnea Clinic for Suspected HFpEF - 2 year(s) ago
Implementation PerspectiveCardiopulmonary Exercise Testing With Simultaneous Echocardiography: Blueprints of a Dyspnea Clinic for Suspected HFpEFKey Wordsambulatory care facilitiesdiastolic heart failuredyspneaechocardiographyexercise testAbbreviations and AcronymsCPETechocardiopulmonary exercise testing with concomitant echocardiographyHFpEFheart failure with preserved ejection…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea - 2 year(s) ago
This case-control study evaluates the performance of the H2FPEF and HFA-PEFF algorithms to diagnose heart failure with preserved ejection fraction among ambulatory patients with dyspnea.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Key message 2: Dyspnoea clinic integrates #heartfailure probability scores, #echofirst, and exercise testing in one. #onestopshop HFA-PEFF & H2FPEF scores very complimentary: https://t.co/kk6Bx0EB1x @yreddyhf @JAMACardio https://t.co/n0UavAT4Oy @ESC_Journals https://t.co/7YQpey0L4A
-
-
Mashup Score: 0Cardiology Tools - 2 year(s) ago
Dear colleague, How do physicians work with the HFpEF diagnostic algorithms as currently recommended by the European and American Heart Failure guidelines (HFA-PEFF and H2FPEF algorithms)? Does it affect the diagnostic decisions? We would like to answer this important question with a small study focused on physicians who evaluate 8 fictional patient cases. Participants…
Source: cardiologytools.comCategories: Cardiologists, Latest HeadlinesTweet-
Dear #HFpEF community, wanna start 2023 with some contribution to science. Here’s an interesting study by @JerremyWeerts to see how physicians use the #HFpEF scores… https://t.co/RTeoAJnKo1 (Takes about 30 min of your time)
-
-
Mashup Score: 8Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea - 2 year(s) ago
This case-control study evaluates the performance of the H2FPEF and HFA-PEFF algorithms to diagnose heart failure with preserved ejection fraction among ambulatory patients with dyspnea.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
@GiuseppeGalati_ @JJheart_doc @TomLuscher @AndrewJSauer @GianluSava @rudolf_deboer @DrDEliaEmilia @PSJhund @markcpetrie20 @DrCCaroli @FormigaFrancesc @Dr_Manito @CNCFCardio @lamcardio @fikkumamoto The key question here is: what constituted the gold standard diagnosis of #HFpEF? The only way to really exclude HFpEF is by #iCPET and even then it can be tricky. Most rigorous effort IMO by @yreddyhf in @JAMACardio https://t.co/kk6Bx0EB1x https://t.co/tyL2mfHY7B
-
-
Mashup Score: 1Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community - 2 year(s) ago
This study sought to describe characteristics and risk of adverse outcomes associated with the H2FPEF and HFA-PEFF scores among participants in the co…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
@GiuseppeGalati_ @JJheart_doc @TomLuscher @AndrewJSauer @GianluSava @rudolf_deboer @DrDEliaEmilia @PSJhund @markcpetrie20 @DrCCaroli @FormigaFrancesc @Dr_Manito @CNCFCardio @lamcardio @fikkumamoto @yreddyhf @JAMACardio Different findings here, for diagnostic purposes, H2FPEF is more accurate and simplier! For prognosis, both scores do well and are complimentary, maybe HFA-PEFF slightly better there, but they are very close... https://t.co/WCvlxRPbpy https://t.co/OHgVE1bY10
-
-
Mashup Score: 1In perspective: Torsemide Comparison With Furosemide For Management of Heart Failure (TRANSFORM-HF) trial - 2 year(s) ago
Frederik H Verbrugge, M.D Ph.D, Venu Menon, M.D; In perspective: Torsemide Comparison With Furosemide For Management of Heart Failure (TRANSFORM-HF) trial, Euro
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Read the #EHJACVC "In perspective" on the Torsemide Comparison With Furosemide For Management of Heart Failure (TRANSFORM-HF) trial https://t.co/tP54LXTkch @venumenon10
-
-
Mashup Score: 0
High-dose isosorbide dinitrate, given as repeated intravenous boluses after low-dose intravenous furosemide, is safe and effective in controlling severe pulmonary oedema. This treatment regimen is more effective than high-dose furosemide with low-dose isosorbide nitrate in terms of need for mechanical ventilation and frequency of myocardial infarction.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
So far, I consider this a fair recommendation... In hyper/normotensive pulmonary oedema, they might be helpful in some cases, with their main benefit a reduced need for (non-)invasive ventilation! Beautiful (older) trial by Gad Cotter on this: https://t.co/pDuXFTHEMo
-
-
Mashup Score: 1
Purpose To date, treatment with intravenous (IV) agents such as vasodilators, diuretics, and inotropes has shown marginal or mixed benefits in acute heart failure (AHF) trials. The aim of this study was to identify the risks and benefits of IV drugs in patients hospitalized with acute decompensated heart failure. Methods The AHF global survey of standard treatment (ALARM-HF) reviewed in-hospital…
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet-
If You remember 1 thing from our paper, let it be: "SBP = awful marker of #afterload or ventriculo-arterial coupling, making it pretty useless in decision to employ #vasodilators" If anything vasodilators work best in patients with LOW SBP: https://t.co/wd9JOvtDMb @AlexMebazaa
-
-
Mashup Score: 0SGLT-2 Inhibitors: Potential Novel Strategy to Prevent Congestive Heart Failure in Diabetes? - Current Cardiovascular Risk Reports - 3 year(s) ago
Sodium-glucose transporter-2 (SGLT-2) inhibitors have emerged as novel oral glucose-lowering agents for type 2 diabetes. SGLT-2 inhibitors improve glycemic control by blocking sodium-glucose cotransport in the renal proximal tubules, thereby promoting glycosuria. In this review, it is discussed mechanistically how SGLT-2 inhibitors might be particularly relevant to use in patients with or at high…
Source: SpringerLinkCategories: Cardiologists, Latest HeadlinesTweet-
@bmorecardiology @drjohnm @escardio Btw, we found out about another medication working in the proximal tubules, suggesting its usefulness in #heartfailure https://t.co/utSV09Jro1 Still proud on this one, it was submitted 5 months before EMPA-REG!
-
-
Mashup Score: 3ESC 22: Hot Line & Late-breaking Science Video Collection - 3 year(s) ago
What’s hot at European Society of Cardiology (ESC) Congress 22? Stay tuned and browse our curated coverage of the latest data in cardiology. For a concise line up of the most
Source: www.ecrjournal.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @radcliffeCARDIO: Take a deep dive into some of the key 🫀data presented at #ESCCongress 📽️👉https://t.co/1gkJjymyky 👉Join host, Dr @hva…
-
Really excited to present our latest paper @JACCJournals on how to organize a #dyspnoeaclinic for #HFpEF! Tweetorial below... https://t.co/WMDyfETR60 Implementation perspective = new item in #JACCHeartFail under @BiykemB leadership! Really the clinician's voice, just love it!